Diagnosis and treatment of pathologic gambling

Erica D. Sood; Stefano Pallanti; Eric Hollander

doi:10.1007/s11920-003-0003-7

Diagnosis and treatment of pathologic gambling

Erica D. Sood
, Stefano Pallanti
, Eric Hollander

Unknown
Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

Pathologic gambling (PG) is an impulse control disorder characterized by recurrent and maladaptive gambling behaviors that significantly disrupt the patient's functioning in the personal, familial, or vocational spheres. Pathologic gambling is estimated to currently affect 1% to 3.4% of the adult US population and is frequently comorbid with substance abuse or dependence, attention-deficit/hyperactivity disorder (ADHD), and affective disorders. Studies show evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the etiology of PG. Medication treatment studies performed in PG patients demonstrated the short-term efficacy of various serotonin reuptake inhibitors, opioid antagonists, and mood stabilizers in a subsample of adult pathologic gamblers who seek treatment. This review focuses on recent research examining the neurobiology and treatment of PG.

Original language	English
Pages (from-to)	9-15
Number of pages	7
Journal	Current Psychiatry Reports
Volume	5
Issue number	1
DOIs	https://doi.org/10.1007/s11920-003-0003-7
State	Published - May 2003
Externally published	Yes

Access to Document

10.1007/s11920-003-0003-7

Cite this

@article{38fff9c1d19c42fd8d3fd08815933d22,

title = "Diagnosis and treatment of pathologic gambling",

abstract = "Pathologic gambling (PG) is an impulse control disorder characterized by recurrent and maladaptive gambling behaviors that significantly disrupt the patient's functioning in the personal, familial, or vocational spheres. Pathologic gambling is estimated to currently affect 1\% to 3.4\% of the adult US population and is frequently comorbid with substance abuse or dependence, attention-deficit/hyperactivity disorder (ADHD), and affective disorders. Studies show evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the etiology of PG. Medication treatment studies performed in PG patients demonstrated the short-term efficacy of various serotonin reuptake inhibitors, opioid antagonists, and mood stabilizers in a subsample of adult pathologic gamblers who seek treatment. This review focuses on recent research examining the neurobiology and treatment of PG.",

author = "Sood, \{Erica D.\} and Stefano Pallanti and Eric Hollander",

year = "2003",

month = may,

doi = "10.1007/s11920-003-0003-7",

language = "English",

volume = "5",

pages = "9--15",

journal = "Current Psychiatry Reports",

issn = "1523-3812",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Diagnosis and treatment of pathologic gambling

AU - Sood, Erica D.

AU - Pallanti, Stefano

AU - Hollander, Eric

PY - 2003/5

Y1 - 2003/5

N2 - Pathologic gambling (PG) is an impulse control disorder characterized by recurrent and maladaptive gambling behaviors that significantly disrupt the patient's functioning in the personal, familial, or vocational spheres. Pathologic gambling is estimated to currently affect 1% to 3.4% of the adult US population and is frequently comorbid with substance abuse or dependence, attention-deficit/hyperactivity disorder (ADHD), and affective disorders. Studies show evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the etiology of PG. Medication treatment studies performed in PG patients demonstrated the short-term efficacy of various serotonin reuptake inhibitors, opioid antagonists, and mood stabilizers in a subsample of adult pathologic gamblers who seek treatment. This review focuses on recent research examining the neurobiology and treatment of PG.

AB - Pathologic gambling (PG) is an impulse control disorder characterized by recurrent and maladaptive gambling behaviors that significantly disrupt the patient's functioning in the personal, familial, or vocational spheres. Pathologic gambling is estimated to currently affect 1% to 3.4% of the adult US population and is frequently comorbid with substance abuse or dependence, attention-deficit/hyperactivity disorder (ADHD), and affective disorders. Studies show evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the etiology of PG. Medication treatment studies performed in PG patients demonstrated the short-term efficacy of various serotonin reuptake inhibitors, opioid antagonists, and mood stabilizers in a subsample of adult pathologic gamblers who seek treatment. This review focuses on recent research examining the neurobiology and treatment of PG.

UR - https://www.scopus.com/pages/publications/0642314885

U2 - 10.1007/s11920-003-0003-7

DO - 10.1007/s11920-003-0003-7

M3 - Review article

C2 - 12685996

AN - SCOPUS:0642314885

SN - 1523-3812

VL - 5

SP - 9

EP - 15

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

IS - 1

ER -

Diagnosis and treatment of pathologic gambling

Abstract

Access to Document

Other files and links

Fingerprint

Cite this